Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia

J. Ben Halima, W. Ben Ahmed, L. El Gharbi, B. Dhari, S. Azzabi, M. A. Baccar, H. Aouina, H. Bouacha (Tunis, Tunisia)

Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Session: Biomarkers, diagnosis and outcome of respiratory infections
Session type: Thematic Poster Session
Number: 2704
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Ben Halima, W. Ben Ahmed, L. El Gharbi, B. Dhari, S. Azzabi, M. A. Baccar, H. Aouina, H. Bouacha (Tunis, Tunisia). Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Eur Respir J 2013; 42: Suppl. 57, 2704

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia
Source: Eur Respir J 2008; 31: 356-362
Year: 2008



Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015


Procalcitonin as etiological marker of severe community-acquired pneumonia
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013


Modern etiology of severe community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


The neutrophil/lymphocyte ratio in predicting outcome for hospitalized patients with community-acquired pneumonia
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014

Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014


Relation between bacteremia and septic shock in patients with pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Impact of diabetes mellitus on inflammatory markers and severity scales in community-acquired pneumonia
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014


Biomarkers and severity in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012


Physical deterioration during hospitalization in patients with community-acquired pneumonia
Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions
Year: 2015


Can procalcitonin or C-reactive protein predict supporative lung complications and ARDS at severe community-acquired pneumonia (CAP)?
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Influence of comorbidities on pneumococcal community-acquired pneumonia
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015


Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015

Community-acquired pneumonia with severe sepsis: Etiology and prognosis
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


Clinical impact of a prediction score for drug-resistance in community-onset pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia
Source: Eur Respir J 2008; 32: 726-732
Year: 2008